Acetylcholinesterase and Nicotinic Acetylcholine Receptors in Schistosomes and Other Parasitic Helminths

Schistosomiasis, which is caused by helminth trematode blood flukes of the genus Schistosoma, is a serious health and economic problem in tropical areas, and the second most prevalent parasitic disease after malaria. Currently, there is no effective vaccine available and treatment is entirely depend...

Full description

Bibliographic Details
Main Authors: Hong You, Chang Liu, Xiaofeng Du, Donald P. McManus
Format: Article
Language:English
Published: MDPI AG 2017-09-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/22/9/1550
_version_ 1828772196534714368
author Hong You
Chang Liu
Xiaofeng Du
Donald P. McManus
author_facet Hong You
Chang Liu
Xiaofeng Du
Donald P. McManus
author_sort Hong You
collection DOAJ
description Schistosomiasis, which is caused by helminth trematode blood flukes of the genus Schistosoma, is a serious health and economic problem in tropical areas, and the second most prevalent parasitic disease after malaria. Currently, there is no effective vaccine available and treatment is entirely dependent on a single drug, praziquantel (PZQ), raising a significant potential public health threat due to the emergence of PZQ drug resistance. It is thus urgent and necessary to explore novel therapeutic targets for the treatment of schistosomiasis. Previous studies demonstrated that acetylcholinesterase (AChE) and nicotinic acetylcholine receptors (nAChRs) play important roles in the schistosome nervous system and ion channels, both of which are targeted by a number of currently approved and marketed anthelminthic drugs. To improve understanding of the functions of the cholinergic system in schistosomes, this article reviews previous studies on AChE and nAChRs in schistosomes and other helminths and discusses their potential as suitable targets for vaccine development and drug design against schistosomiasis.
first_indexed 2024-12-11T14:40:00Z
format Article
id doaj.art-3a150299179149a0816afbf56234862a
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-12-11T14:40:00Z
publishDate 2017-09-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-3a150299179149a0816afbf56234862a2022-12-22T01:01:59ZengMDPI AGMolecules1420-30492017-09-01229155010.3390/molecules22091550molecules22091550Acetylcholinesterase and Nicotinic Acetylcholine Receptors in Schistosomes and Other Parasitic HelminthsHong You0Chang Liu1Xiaofeng Du2Donald P. McManus3Molecular Parasitology Laboratory, Infectious Diseases Division, QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4006, AustraliaMolecular Parasitology Laboratory, Infectious Diseases Division, QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4006, AustraliaMolecular Parasitology Laboratory, Infectious Diseases Division, QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4006, AustraliaMolecular Parasitology Laboratory, Infectious Diseases Division, QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4006, AustraliaSchistosomiasis, which is caused by helminth trematode blood flukes of the genus Schistosoma, is a serious health and economic problem in tropical areas, and the second most prevalent parasitic disease after malaria. Currently, there is no effective vaccine available and treatment is entirely dependent on a single drug, praziquantel (PZQ), raising a significant potential public health threat due to the emergence of PZQ drug resistance. It is thus urgent and necessary to explore novel therapeutic targets for the treatment of schistosomiasis. Previous studies demonstrated that acetylcholinesterase (AChE) and nicotinic acetylcholine receptors (nAChRs) play important roles in the schistosome nervous system and ion channels, both of which are targeted by a number of currently approved and marketed anthelminthic drugs. To improve understanding of the functions of the cholinergic system in schistosomes, this article reviews previous studies on AChE and nAChRs in schistosomes and other helminths and discusses their potential as suitable targets for vaccine development and drug design against schistosomiasis.https://www.mdpi.com/1420-3049/22/9/1550schistosomeacetylcholinesterasenicotinic acetylcholine receptorsdrug targetsvaccine targets
spellingShingle Hong You
Chang Liu
Xiaofeng Du
Donald P. McManus
Acetylcholinesterase and Nicotinic Acetylcholine Receptors in Schistosomes and Other Parasitic Helminths
Molecules
schistosome
acetylcholinesterase
nicotinic acetylcholine receptors
drug targets
vaccine targets
title Acetylcholinesterase and Nicotinic Acetylcholine Receptors in Schistosomes and Other Parasitic Helminths
title_full Acetylcholinesterase and Nicotinic Acetylcholine Receptors in Schistosomes and Other Parasitic Helminths
title_fullStr Acetylcholinesterase and Nicotinic Acetylcholine Receptors in Schistosomes and Other Parasitic Helminths
title_full_unstemmed Acetylcholinesterase and Nicotinic Acetylcholine Receptors in Schistosomes and Other Parasitic Helminths
title_short Acetylcholinesterase and Nicotinic Acetylcholine Receptors in Schistosomes and Other Parasitic Helminths
title_sort acetylcholinesterase and nicotinic acetylcholine receptors in schistosomes and other parasitic helminths
topic schistosome
acetylcholinesterase
nicotinic acetylcholine receptors
drug targets
vaccine targets
url https://www.mdpi.com/1420-3049/22/9/1550
work_keys_str_mv AT hongyou acetylcholinesteraseandnicotinicacetylcholinereceptorsinschistosomesandotherparasitichelminths
AT changliu acetylcholinesteraseandnicotinicacetylcholinereceptorsinschistosomesandotherparasitichelminths
AT xiaofengdu acetylcholinesteraseandnicotinicacetylcholinereceptorsinschistosomesandotherparasitichelminths
AT donaldpmcmanus acetylcholinesteraseandnicotinicacetylcholinereceptorsinschistosomesandotherparasitichelminths